Drugs target to RYR3

Drug name Drug type Disease/phenotype Mechanism of action(MoA) Phase Status Source
DANTROLENE SODIUMSmall moleculestrokeRyanodine receptor 3 antagonist4.0-DailyMed
DANTROLENESmall moleculemultiple sclerosisRyanodine receptor 3 antagonist1.0RecruitingClinicalTrials
DANTROLENE SODIUMSmall moleculeFeverRyanodine receptor 3 antagonist4.0-DailyMed
DANTROLENESmall moleculeFeverRyanodine receptor 3 antagonist4.0-DailyMed
DANTROLENESmall moleculeventricular tachycardiaRyanodine receptor 3 antagonist2.0RecruitingClinicalTrials
DANTROLENESmall moleculeWolfram syndromeRyanodine receptor 3 antagonist1.0Active, not recruitingClinicalTrials
DANTROLENESmall moleculestrokeRyanodine receptor 3 antagonist4.0-DailyMed
DANTROLENE SODIUMSmall moleculedrug toxicityRyanodine receptor 3 antagonist2.0TerminatedClinicalTrials
DANTROLENE SODIUMSmall moleculeSpinal cord injuryRyanodine receptor 3 antagonist4.0-DailyMed
DANTROLENESmall moleculeinjuryRyanodine receptor 3 antagonist2.0RecruitingClinicalTrials
DANTROLENESmall moleculecerebral palsyRyanodine receptor 3 antagonist4.0-DailyMed
DANTROLENE SODIUMSmall moleculeSpasticityRyanodine receptor 3 antagonist4.0-DailyMed
DANTROLENE SODIUMSmall moleculeWolfram syndromeRyanodine receptor 3 antagonist1.0Active, not recruitingClinicalTrials
DANTROLENE SODIUMSmall moleculeHeat StrokeRyanodine receptor 3 antagonist2.0CompletedClinicalTrials
DANTROLENESmall moleculeSpasticityRyanodine receptor 3 antagonist4.0-DailyMed
DANTROLENESmall moleculedrug toxicityRyanodine receptor 3 antagonist2.0TerminatedClinicalTrials
DANTROLENESmall moleculeHeat StrokeRyanodine receptor 3 antagonist2.0CompletedClinicalTrials
DANTROLENE SODIUMSmall moleculemultiple sclerosisRyanodine receptor 3 antagonist4.0-DailyMed
DANTROLENESmall moleculeFeverRyanodine receptor 3 antagonist2.0TerminatedClinicalTrials
DANTROLENE SODIUMSmall moleculecerebral palsyRyanodine receptor 3 antagonist4.0-DailyMed
DANTROLENESmall moleculeSpinal cord injuryRyanodine receptor 3 antagonist4.0-DailyMed
DANTROLENESmall moleculemultiple sclerosisRyanodine receptor 3 antagonist4.0-DailyMed